Panel rejects FDA's wish to use antipsychotics in children

11/18/2008 |

An advisory committee opted not to support the FDA in its acceptance of using two psychiatric drugs in children. The panel criticized agency regulations on prescribing Johnson & Johnson's Risperdal and Eli Lilly and Co.'s Zyprexa for children and called for more efforts to curb their growing use, particularly for off-label treatment of ADHD.

View Full Article in:

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
Palm Springs, CA